浦银安盛数字经济混合A
Search documents
基金回报榜:243只基金昨日回报超5%
Zheng Quan Shi Bao Wang· 2025-12-09 01:20
Core Insights - The stock and mixed funds achieved a positive return of 70.27% on December 8, with 243 funds returning over 5% and 472 funds experiencing a net value drawdown exceeding 1% [1][2] Fund Performance - The Shanghai Composite Index rose by 0.54% to close at 3924.08 points, while the Shenzhen Component Index increased by 1.39%, the ChiNext Index by 2.60%, and the STAR 50 Index by 1.86% [1] - The top-performing sectors included telecommunications, comprehensive, and electronics, with increases of 4.79%, 3.03%, and 2.60% respectively. Conversely, coal, oil and petrochemicals, and food and beverage sectors saw declines of 1.43%, 0.84%, and 0.78% respectively [1] - The average net value growth rate for stock and mixed funds on December 8 was 0.80% [1] Top Funds - The fund with the highest net value growth rate was Guorong Rongxin Consumer Select Mixed C, achieving a growth rate of 10.01%. Other notable funds included Guorong Rongxin Consumer Select Mixed A (10.00%), and Guoshou Anbao Strategy Selected Mixed A (9.14%) [2] - Among the funds with a net value growth rate exceeding 5%, 142 were equity funds, 41 were flexible allocation funds, and 34 were index equity funds [2] Drawdown Analysis - A total of 472 funds experienced a drawdown exceeding 1%, with the largest drawdown recorded by Huatai-PB Hong Kong Stock Connect Medical Selected Mixed Initiated C, which saw a decline of 2.40% [2][4] - Other funds with significant drawdowns included Huatai-PB Hong Kong Stock Connect Medical Selected Mixed Initiated A (-2.40%), and Yin Hua Fu Li Selected Mixed C (-2.32%) [4]
基金早班车丨新基发行两连降,FOF与债基撑起冷清档期
Sou Hu Cai Jing· 2025-11-26 00:47
Group 1: Market Overview - The fund issuance continues to show a cold trend, with only 23 new funds launched from November 24 to 30, representing a 32% decrease compared to the previous period, and the average subscription period extended to 23.65 days [1] - On November 25, A-shares saw a rise in the three major indices, with the Shanghai Composite Index up 0.87% to 3870.02 points, the Shenzhen Component Index up 1.53% to 12777.31 points, and the ChiNext Index up 1.77% to 2980.93 points, with a total market turnover of 1.81 trillion [1] Group 2: Fund News - No new funds were launched on November 25, but 50 funds distributed dividends, primarily bond funds, with the highest dividend payout from the Guotai Haitong CSI 1000 Preferred Stock Fund at 3.1760 yuan per 10 shares [2] - Despite A-share adjustments triggering risk aversion, public funds are operating contrary to expectations, with bond funds, money market funds, and dividend-themed products recently implementing purchase limits while broad-based equity indices are seeing accelerated new fund launches [2] - As of November 25, there are 80 public fund products in the market with a total planned fundraising amount exceeding 210 billion yuan, indicating a moderate recovery expectation and an optimized investor structure [2] Group 3: Fund Performance - On November 25, the best-performing fund was the浦银安盛数字经济混合A, with a daily growth rate of 6.5864%, followed closely by the 华商均衡成长混合C at 6.5856% and the 华商均衡成长混合A at 6.5849% [5] - In terms of investment types, the top-performing stock fund was 同泰行业优选股票C with a daily growth rate of 6.0587%, while the top bond fund was 南方昌元转债C with a growth rate of 1.5297% [6]
浦银安盛蒋佳良“三连亏”:新发医药基金上市即亏
Sou Hu Cai Jing· 2025-10-20 07:35
Core Insights - The public fund industry in China has surpassed 33 trillion yuan, but浦银安盛基金 is facing a "performance dilemma" in equity investments, with all three core products managed by CIO 蒋佳良 showing negative returns exceeding 15% [1][2] - The flagship product, 浦银安盛品质优选混合A, has declined by 46.9% since its inception at the end of 2021, ranking near the bottom among similar funds [1][2] - Despite the poor performance of existing products, the company continues to launch new funds, with 10 new funds issued in 2025, including 4 active equity products, three of which have already reported losses [1][7] Performance Analysis - 蒋佳良 manages 8 products with a total scale of approximately 1.17 billion yuan, representing about one-fifth of the company's equity fund assets [2] - The three actively managed equity products have returns of -46.90%, -18.76%, and -6.78% as of October 17, 2025, all negative [2] - The flagship fund has seen its net value drop to 0.531 yuan, with an annualized return of -15.32%, significantly underperforming the benchmark [2][5] Investment Strategy Issues - The investment strategy has shown clear misalignment, with a focus on new energy and vehicle manufacturing in 2022 leading to losses, and a missed opportunity in the AI sector in 2023 [5] - The fund's turnover rate has remained high, exceeding 480% in 2024, indicating a lack of stability in investment style [5] - High management fees have drawn criticism, as the flagship fund has incurred over 690 million yuan in management fees while reporting significant losses [5][6] New Fund Launches - In 2025, the company launched 10 new funds, including 4 active equity funds, but three of these have already reported losses shortly after their inception [7] - The newly launched active equity products have underperformed significantly compared to the market, with losses of -7.21% and -11.74% for two of the funds [7] Company Growth and Challenges - Despite a high frequency of fund launches, the overall growth in fund size has been limited, with the company managing approximately 361.7 billion yuan in public fund assets as of mid-2025 [8] - The reliance on frequent product launches without a strong flagship fund has weakened investor confidence [8] - Regulatory changes are pushing for higher quality in fund management, emphasizing the need for clear performance benchmarks and investment positioning [8]